PolyGlycopleX (PGX)
Dietary Supplementpowder, 5 grams, 3 times per day at each main meal (breakfast, lunch and dinner) for a total of 3 days
NCT Number: NCT01108328
The objective of the study is to compare subjective appetite ratings and after-meal and 24 hour blood glucose levels within overweight and obese female subjects consuming either a standardized 3 day low calorie diet supplemented with a viscous fibre known as PGX (treatment) or a rice flour (placebo control). Each treatment phase will be 3 days in length and separated by 3 week washout phase, so subjects will also be acting as their own control. Subjects will be randomized to either start with the low calorie diet with PGX or the low calorie diet supplemented with rice flour. We hypothesize that the 3 day LCD with PGX will elicit an improved appetite score compared to the 3 day LCD supplemented with the rice flour placebo control.
Looking for future studies?
Notify Me20 year–50 year
Female
Interventional
Phase 3
Canadian Center for Functional Medicine, Coquitlam, British Columbia, Canada
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
powder, 5 grams, 3 times per day at each main meal (breakfast, lunch and dinner) for a total of 3 days
Time frame: 3 days
Time frame: 3 days
Canadian Center for Functional Medicine
Other
A Prospective, Single Crossover, Randomized, Double Blind Placebo Controlled Trial Evaluating Subjective Ratings of Appetite and Glucoregulation of a Low Calorie Diet Supplemented With a High Viscosity Polysaccharide (PolyGlycopleX - PGX) vs. Rice Flour Control, in Overweight and Moderately Obese Females.
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT01580150
Blood Glucose, Postprandial, Blood Insulin, Postprandial
Kuopio, Finland
View Trial DetailsNCT00935350
Blood Glucose, Postprandial
Toronto, Ontario, Canada
View Trial DetailsNCT00801814
Blood Glucose, Postprandial
Toronto, Ontario, Canada
View Trial Details